These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cerebral atrophy in young cannalis smokers. Schwarz CJ Lancet; 1972 Feb; 1(7746):374. PubMed ID: 4109753 [No Abstract] [Full Text] [Related]
7. Cannabis and cerebral atrophy. Evans M R Soc Health J; 1974 Feb; 94(1):15-8. PubMed ID: 4845446 [No Abstract] [Full Text] [Related]
8. Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography. Co BT; Goodwin DW; Gado M; Mikhael M; Hill SY JAMA; 1977 Mar; 237(12):1229-30. PubMed ID: 576460 [TBL] [Abstract][Full Text] [Related]
9. Cerebral atrophy in young cannabis smokers. Campbell AM; Evans M; Thomson JL; Williams MJ Lancet; 1971 Dec; 2(7736):1219-24. PubMed ID: 4143590 [TBL] [Abstract][Full Text] [Related]
10. Computed tomographic examination of heavy marijuana smokers. Kuehnle J; Mendelson JH; Davis KR; New PF JAMA; 1977 Mar; 237(12):1231-2. PubMed ID: 576461 [TBL] [Abstract][Full Text] [Related]
11. [Toxic effects of chronic misuse of cannabis]. Retterstol N Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2124-5. PubMed ID: 4204258 [No Abstract] [Full Text] [Related]
15. Cannabis and the brain. J Ir Med Assoc; 1972 Oct; 65(19):493. PubMed ID: 5073344 [No Abstract] [Full Text] [Related]
16. Psychotic symptoms due to cannabis abuse; (a survey of newly admitted mental patients). Keup W Dis Nerv Syst; 1970 Feb; 31(2):119-26. PubMed ID: 5438330 [No Abstract] [Full Text] [Related]
17. Equillibrium disorders with diffuse brain atrophy in long-term toluene sniffing. Sasa M; Igarashi S; Miyazaki T; Miyazaki K; Nakano S; Matsuoka I Arch Otorhinolaryngol; 1978 Oct; 221(3):163-9. PubMed ID: 736823 [TBL] [Abstract][Full Text] [Related]
18. Adverse effects of cannabis and cannabinoids. Holdcroft A Br J Anaesth; 2000 Mar; 84(3):419-20. PubMed ID: 10793614 [No Abstract] [Full Text] [Related]
19. Ataxia and dementia due to thinner abuse. Viana Bde M; Moura Ade S; Moreira JM; Prais HA; Cardoso F Mov Disord; 2009 Sep; 24(12):1850-2. PubMed ID: 19609910 [No Abstract] [Full Text] [Related]
20. The ocular manifestations of the cannabinols. Shapiro D Ophthalmologica; 1974; 168(5):366-9. PubMed ID: 4832043 [No Abstract] [Full Text] [Related] [Next] [New Search]